ABSCI CORP
ABSINASDAQ🏆 #1952 by market capUS Equity
$11.89▲ $1.32 (+12.49%)
After hours · at closeTrack ABSI
Get earnings, price moves & breaking news on Telegram
24h▲ 12.5%
7d▲ 18.4%
14d▲ 35.9%
30d▲ 25.2%
ytd▲ 241.2%
1y▲ 170.8%
🏦Market Cap
$2.04B
Small Cap
📈Revenue Growth (YoY)
-38.2%
Declining
📊Gross Margin
-255.9%
Thin
💵FCF Margin
-6981.0%
Thin
⚖️P/S Ratio
1162.0x
Expensive
Otter Score
36
Weak
Trading Snapshot
- Day Range
- $10.44 – $11.89
- 52-Week Range
- $2.24 – $12.06
- Volume (shares)
- 410,582
- Avg Volume (shares)
- —
- Shares Outstanding
- 171.6M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $3M
- Last Q Revenue
- $318,000
- P/E Ratio
- -13.2
- P/S Ratio
- 1162.0x
- EPS (TTM)
- $-0.77
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +31.0%
ABSCI CORP
ABSIFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$3M▼ −38.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-319.4%▼ −75.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$125M▲ +14.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$94M▲ +29.2% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
150.6M▲ +31.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$15M▼ −$16M YoY
StockOtter · stockotter.spaceAbout ABSCI CORP
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
36/100
Analyst data unavailable.
Latest News & Updates
News unavailable.